Evidence map›Paper›PMID 39580482›Full record

ArticleNature communications2024

An automatic end-to-end chemical synthesis development platform powered by large language models.

Yixiang Ruan, Chenyin Lu, Ning Xu, Yuchen He, Yixin Chen, Jian Zhang, Jun Xuan, Jianzhang Pan, Qun Fang, Hanyu Gao and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Transforming Molecular Synthesis With Large Language Models.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yixiang RuanCollege of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Chenyin LuZhejiang-Hong Kong Joint Laboratory for Intelligent Molecule and Material Design and Synthesis, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311215, China.
Ning XuCollege of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Yuchen HeCollege of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Yixin ChenCollege of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Jian ZhangZhejiang-Hong Kong Joint Laboratory for Intelligent Molecule and Material Design and Synthesis, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311215, China.
Jun XuanZhejiang-Hong Kong Joint Laboratory for Intelligent Molecule and Material Design and Synthesis, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311215, China.
Jianzhang PanZhejiang-Hong Kong Joint Laboratory for Intelligent Molecule and Material Design and Synthesis, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311215, China.ORCID 0000-0001-8164-7161
Qun FangZhejiang-Hong Kong Joint Laboratory for Intelligent Molecule and Material Design and Synthesis, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311215, China.
Hanyu GaoDepartment of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, 999077, China.ORCID 0000-0002-6346-0739
Xiaodong ShenChemical & Analytical Development, Suzhou Novartis Technical Development Co. Ltd., Changshu, 215537, China.
Ning YeRezubio Pharmaceuticals Co. Ltd., Zhuhai, 519070, China.ORCID 0000-0003-2637-6893
Qiang ZhangZhejiang-Hong Kong Joint Laboratory for Intelligent Molecule and Material Design and Synthesis, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311215, China.ORCID 0000-0003-1636-5269
Yiming MoCollege of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China. yimingmo@zju.edu.cn.ORCID 0000-0002-7031-1133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid emergence of large language model (LLM) technology presents promising opportunities to facilitate the development of synthetic reactions. In this work, we leveraged the power of GPT-4 to build an LLM-based reaction development framework (LLM-RDF) to handle fundamental tasks involved throughout the chemical synthesis development. LLM-RDF comprises six specialized LLM-based agents, including Literature Scouter, Experiment Designer, Hardware Executor, Spectrum Analyzer, Separation Instructor, and Result Interpreter, which are pre-prompted to accomplish the designated tasks. A web application with LLM-RDF as the backend was built to allow chemist users to interact with automated experimental platforms and analyze results via natural language, thus, eliminating the need for coding skills and ensuring accessibility for all chemists. We demonstrated the capabilities of LLM-RDF in guiding the end-to-end synthesis development process for the copper/TEMPO catalyzed aerobic alcohol oxidation to aldehyde reaction, including literature search and information extraction, substrate scope and condition screening, reaction kinetics study, reaction condition optimization, reaction scale-up and product purification. Furthermore, LLM-RDF's broader applicability and versability was validated on various synthesis tasks of three distinct reactions (S

Indexed as

CopperAlcoholsAldehydesCatalysisChemistry Techniques, SyntheticCyclic N-OxidesKineticsOxidation-ReductionSoftwareAlcoholsAldehydesCopperCyclic N-OxidesTEMPO

Identifiers

PMID39580482
PMCPMC11585555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.